To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Departmental Publication (Statistics)
Department for Work and Pensions

May. 23 2024

Source Page: Plan for Jobs Cross-cutting Evaluation Wave 1 and 2 synthesis report
Document: (PDF)

Found: Customer health profile Across all PfJ strands, physical and mental health conditions, which can act

Non-Departmental Publication (Statistics)
NHS Digital

May. 23 2024

Source Page: Maternity Services Monthly Statistics, Final February 2024, Provisional March 2024, experimental statistics
Document: Maternity Services Monthly Statistics, Final February 2024, Provisional March 2024, experimental statistics (webpage)

Found: The data collected include mother’s demographics, booking appointments, admissions and re-admissions, screening

Written Question
Neurofibromatosis: Breast Cancer
Thursday 23rd May 2024

Asked by: Liz Twist (Labour - Blaydon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of automatically notifying women with neurofibromatosis type 1 before their 40th birthday that they are eligible to attend breast cancer screening from the age of 40 years.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

Currently women with neurofibromatosis type 1 (NF1) who are considered at moderate or high risk of breast cancer, can be referred through clinical professionals such as specialists in genetics or oncology for annual breast screening which is managed at a local level.

An assessment has not made of the potential merits of automatically notifying women with NF1 before they are 40 years old that they are eligible to attend breast cancer screening from the age of 40 years.

Written Question
Neurofibromatosis: Breast Cancer
Thursday 23rd May 2024

Asked by: Liz Twist (Labour - Blaydon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she has taken with NHS England to help raise awareness by (a) patients and (b) GPs of the increased risk of breast cancer in people with neurofibromatosis type 1.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

The Department works with NHS England to raise awareness of cancers, including for people with increased risk of cancer. In January 2024, NHS England relaunched the Help Us Help You cancer awareness campaign, designed to increase earlier diagnosis by encouraging people to come forward with suspected signs of cancers.

For individuals with neurofibromatosis type 1 (NF1), who are at increased risk of breast cancer, the National Health Service in England recommends breast screening from the age of 40 years old. It is important that awareness of this is widespread among patients and general practices (GPs). Treatment for NF1 involves regular monitoring, and if a patient develops complex problems, their GP can usually refer them to one of two specialist NHS centres, so that a treatment plan can be drawn up. These centres are at Guy’s and St Thomas’ in London, and at Manchester University Hospital.

We expect clinicians to keep themselves appraised of developments within conditions, and to refer to the National Institute for Clinical Excellence guidance as part of their clinical decision-making process.

Select Committee
University of Essex
 FDO0069 - Food, Diet and Obesity

Written Evidence May. 22 2024

Inquiry: Food, Diet and Obesity
Inquiry Status: Closed
Committee: Food, Diet and Obesity Committee

Found: This is associated with reduced uptake of preventive screening, including for a range of cancers

Select Committee
University of Liverpool, University of Liverpool, University of Liverpool, Dr Brendan Collins, Dr Yanaina Chavez-Ugalde, and Dr Simon Capewell
 FDO0071 - Food, Diet and Obesity

Written Evidence May. 22 2024

Inquiry: Food, Diet and Obesity
Inquiry Status: Closed
Committee: Food, Diet and Obesity Committee

Found: Discussion Our initial analysis suggests that ultra-processed foods and drinks make a substantial health

Select Committee
London School of Hygiene and Tropic
 FDO0073 - Food, Diet and Obesity

Written Evidence May. 22 2024

Inquiry: Food, Diet and Obesity
Inquiry Status: Closed
Committee: Food, Diet and Obesity Committee

Found: on Climate Change and Planetary Health as well as leading the Planetary Health research group.

Select Committee
Bayes Business School, City, University of London, and Bayes Business School, City, University of London
 FDO0057 - Food, Diet and Obesity

Written Evidence May. 22 2024

Inquiry: Food, Diet and Obesity
Inquiry Status: Closed
Committee: Food, Diet and Obesity Committee

Found: Further screening would be indicated.Further reading Ashwell M, Mayhew L, Richardson J, Rickayzen,B.

Departmental Publication (Guidance and Regulation)
Home Office

May. 22 2024

Source Page: Immigration Rules archive: 11 April 2024 to 15 May 2024
Document: (PDF)

Found: Health Service foundation trust; and (b) in relation to Wales - (i) a Local Health Board established

Select Committee
Okayama University, Cambridge Judge Business School, University of Cambridge, and Harvard T.H. Chan School of Public Health, Harvard University
 FDO0023 - Food, Diet and Obesity

Written Evidence May. 22 2024

Inquiry: Food, Diet and Obesity
Inquiry Status: Closed
Committee: Food, Diet and Obesity Committee

Found: Chan School of Public Health, Harvard University Written Evidence